Document is current
Any future updates will be listed below
-
Authors
Silberbauer, Leo R. https://orcid.org/0000-0002-8521-1012
Reed, Murray B.
Gryglewski, Gregor https://orcid.org/0000-0002-7344-8071
Murgaš, Matej https://orcid.org/0000-0001-7643-2182
Nics, Lukas
Godbersen, Godber Mathis https://orcid.org/0000-0002-9739-0724
Stimpfl, Thomas https://orcid.org/0000-0003-0418-1809
Hahn, Andreas https://orcid.org/0000-0001-9727-7580
Hacker, Marcus https://orcid.org/0000-0002-4222-4083
Lanzenberger, Rupert https://orcid.org/0000-0003-4641-9539
-
Funding
Funding for this research was provided by:
Austrian Science Fund (https://doi.org/10.55776/KLI1006)
Austrian Science Fund (https://doi.org/10.55776/DOC33)
Austrian Science Fund (https://doi.org/10.55776/KLI504)
Vienna Science and Technology Fund (https://doi.org/10.47379/CS18039)
Else Kröner-Fresenius-Stiftung (2014_A192)
Österreichischen Akademie der Wissenschaften (DOC)
Österreichischen Akademie der Wissenschaften (DOC)
- License Information
-
More Information
Article History
Received: 29 June 2025
Revised: 12 December 2025
Accepted: 20 January 2026
First Online: 3 February 2026
Competing interests
: R. Lanzenberger received investigator-initiated research funding from Siemens Healthcare regarding clinical research using PET/MR. He is a shareholder of the start-up company BM Health GmbH since 2019. M. Hacker received consulting fees and/or honoraria from Bayer Healthcare BMS, Eli Lilly, EZAG, GE Healthcare, Ipsen, ITM, Janssen, Roche, Siemens Healthineers. The remaining authors declare no potential conflict of interest with respect to the research, authorship, and/ or publication of this article.
